Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening.
about
Colorectal cancer screening: 20 years of development and recent progressThe Direct Medical Costs of Colorectal Cancer in Iran; Analyzing the Patient's Level Data from a Cancer Specific Hospital in Isfahan.The performance of three-sample qualitative immunochemical fecal test to detect colorectal adenoma and cancer in gastrointestinal outpatients: an observational studyParticipant uptake of the fecal immunochemical test decreases with the two-sample regimen compared with one-sample FITAdvances in Fecal Occult Blood Tests: the FIT revolution.An economic evaluation of colorectal cancer screening in primary care practiceFecal immunochemical test accuracy in average-risk colorectal cancer screening.Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.Cost-effectiveness of high-sensitivity faecal immunochemical test and colonoscopy screening for colorectal cancer.Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer.Impact of Fecal Hb Levels on Advanced Neoplasia Detection and the Diagnostic Miss Rate For Colorectal Cancer Screening in High-Risk vs. Average-Risk Subjects: a Multi-Center Study.Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age.Clinical utility of one versus two faecal immunochemical test samples in the detection of advanced colorectal neoplasia in symptomatic patients.
P2860
Q27014870-190715DF-6126-48AD-8A55-A248DB7B31DCQ30583494-748B873F-CAD0-4711-AE91-E8E8ECD8F8DBQ34149862-3E2421D2-D6D2-4040-AA49-DCED54D67A92Q34293908-AE2B04AD-F7C2-440B-B94F-0389607D4D0BQ34666990-B919F788-B42D-4C71-BCA6-7730669A882FQ35638541-D8B6ED63-D76B-4667-86C7-8271AE89D57BQ37578685-209F3215-5132-42BF-95AE-83220147B918Q38515202-869001A6-172B-44DC-942B-6A8D148BBC6EQ38754674-94E6C591-B70C-4691-BA06-A13EAD59C98CQ38983778-D6D6891E-1194-4D82-ACD6-8FAD65B02F83Q39773261-35CD1442-C675-408F-88BC-EFEDC981EE26Q40540045-9EFAAE83-5066-4586-9A88-7DA5E1AD8276Q47137106-F189CBD8-C6DB-483C-9A4B-1C945BBF4879Q50432002-F71321E1-FA31-4FEE-BAB3-5F834AD5FD22Q50873130-E6A580F8-0E7E-4897-BD71-2E6DDA9617D2Q50958798-57B61583-F444-4711-B513-027E872A967B
P2860
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cost-effectiveness of one vers ...... r colorectal cancer screening.
@ast
Cost-effectiveness of one vers ...... r colorectal cancer screening.
@en
type
label
Cost-effectiveness of one vers ...... r colorectal cancer screening.
@ast
Cost-effectiveness of one vers ...... r colorectal cancer screening.
@en
prefLabel
Cost-effectiveness of one vers ...... r colorectal cancer screening.
@ast
Cost-effectiveness of one vers ...... r colorectal cancer screening.
@en
P2093
P2860
P50
P1433
P1476
Cost-effectiveness of one vers ...... r colorectal cancer screening.
@en
P2093
Aafke H C van Roon
Anneke J van Vuuren
J Dik F Habbema
Jacqueline C I Y Reijerink
Monique E van Leerdam
S Lucas Goede
P2860
P304
P356
10.1136/GUTJNL-2011-301917
P407
P577
2012-04-05T00:00:00Z